Aller au contenu principal
2022 preprint

A Multidisciplinary Intervention to Improve Hepatocellular (HCC) Screening rates in an Advanced Liver Disease (ALD) Veteran Population

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

Background: Hepatocellular carcinoma (HCC) is one of the leading causes of death among patients with Advanced Liver Disease (ALD). Patients with ALD have approximately 2-4% yearly risk of developing HCC. The 2018 American Association for the Study of Liver Diseases (AASLD) recommends surveillance using ultrasound (US), with or without alpha fetal protein (AFP) measurement every 6 months. Studies show low HCC surveillance rates of about 20% among people with ALD. In a study, 88% of HCVinfected Veterans with ALD within the VA health care system did not receive routine HCC surveillance as recommended by national guidelines. Purpose/Specific Aims: The purpose of this scholarly project is to increase HCC screening rates in patients with ALD at Providence Veterans Affairs Medical Center (PVAMC) by developing effective multidisciplinary ALD screening program. Specific aims are to examine how multidisciplinary interventions can improve team’s compliance with national HCC guidelines, measured by increase HCC screening rates among patients with ALD. Methods: Univariate descriptive design was used for this quality improvement project. The sample included veterans with diagnosis of ALD. The project was conducted at an outpatient hepatology clinic at PVAMC. The intervention included offering same day walk-in ultrasound for veterans with ALD. Baseline data on the rates of screening abdominal ultrasounds were collected, and post-intervention data was collected for five months. Differences between pre and post intervention data were analyzed using chi square. Results: This project resulted in increased HCC ultrasound screening rates among ALD patients, and an increase in provider’s compliance with national HCC screening guidelines. Conclusion: AASLD guidelines recommends every 6 months screening ultrasounds for HCC surveillance in patients with ALD. At PVAMC, providing veterans with same day walk-in ultrasounds to coincide with their liver clinic appointment eliminated a number of barriers to HCC screening, and lead to increase in compliance.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
A Multidisciplinary Intervention to Improve Hepatocellular (HCC) Screening rates in an Advanced Liver Disease (ALD) Veteran Population
Date Crossref
14/05/2022
Éditeur
James P. Adams Library, Rhode Island College
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Liver Disease Diagnosis and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.